Previous 10 | Next 10 |
NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to present at the Goldman Sachs 43 rd Annual Global Healthcare Conference on June 14, 2022 at 2:20 p.m. ET. The webcast will be accessible from Royalty Pharma’...
Halvorsen's 13F portfolio value decreased from $34.49B to $24.74B this quarter. The number of positions decreased from 107 to 56. Viking Global increased Amazon.com, Fortive, and International Flavors & Fragrances while dropping Humana, Coupa Software, and Twilio. The top thre...
This Buffett holdings list from Kiplinger first appeared 5/17/22 on line. YCharts and Dogs of The Dow also track this Buffett/Berkshire batch. Here is your update from 5/27/22 YCharts data. 32 of 49 current Berkshire-Hathaway-owned-stocks pay dividends. As of 5/27/22 the top-ten range...
Insiders scaled back their buying after three weeks of elevated buying. Despite the huge declines in their stock, insiders continue to sell. Last week, we also saw 7 different insiders of DoorDash, including the CFO and General Counsel, sell stock. For further details see: ...
Royalty Pharma lets you diversify within the healthcare sector. A bear market is actually conducive to its business model. They have no competition in their niche. For further details see: Royalty Pharma: Unique Diversification, Bear Market Performer
NEW YORK, May 23, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to present at the UBS Global Healthcare Conference 2022 on May 24, 2022 at 1:15 p.m. ET. The webcast will be accessible from Royalty Pharma’s “Events”...
Berkshire Hathaway's 13F stock portfolio value increased from ~$331B to ~$364B. Their largest three holdings are at ~62% of the entire portfolio. Berkshire Hathaway added Occidental Petroleum, HP, Citigroup, and Paramount Global while reducing Verizon Communications. They also inc...
New capital deployment target of $10-12 billion over the next five years Outlook for 2020-2025 Adjusted Cash Receipts (1) (non-GAAP) CAGR raised to 11-14% Adjusted Cash Receipts (1) (non-GAAP) expected to grow 10% or more over this decade, positio...
Berkshire Hathaway (BRK.B) (BRK.A), the investment giant built by Warren Buffett, disclosed a new stake in Citigroup (NYSE:C) with ~55.2M shares, amounting to ~2.5% of Citi's outstanding shares, it acquired in the first quarter of 2022, according to Berkshire's 13F filing. The company had alr...
While XOMA offers an investment into an important sector of healthcare, drug revenue royalties, the story is just beginning. From first glance, years of losses and flat revenues look poor, but something special is hidden underneath. Those looking to get in before the story plays o...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Molly Sawaya as Executive Vice President, Head of Human Capital. Molly joins Royalty Pharma from Hudson Bay Capital, where she was a Managing Director and Head of Colleague Experie...
2024-07-24 08:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its second quarter 2024 financial results on Thursday, August 8, 2024 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 ...